FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4013011000001100: Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21915701000001117 Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21915801000001114 Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Is pack of Allantoin 10.25mg / Lidocaine 10.25mg suppositories false Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Has active ingredient Allantoin false Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Has VMP Allantoin 10.25mg / Lidocaine 10.25mg suppositories true Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Has specific active ingredient Allantoin true Inferred relationship Existential restriction modifier
Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Anodesyn suppositories (Thornton & Ross Ltd) 12 suppository Is a True Allantoin 10.25mg / Lidocaine 10.25mg suppositories 12 suppository Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start